Propanc Biopharma, Inc. (PPCB)
OTCMKTS
· Delayed Price · Currency is USD
5.25
-0.25 (-4.55%)
Apr 4, 2025, 2:39 PM EST
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $80.70 thousand as of April 4, 2025. Its market cap has decreased by -59.72% in one year.
Market Cap
80.70K
Enterprise Value
1.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.25
Market Cap Chart
Since February 14, 2022, Propanc Biopharma's market cap has decreased from 1.26M to 80.70K, a decrease of -93.58%. That is a compound annual growth rate of -58.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 84.55K | -49.01% |
Dec 31, 2024 | 165.82K | -50.41% |
Dec 29, 2023 | 334.41K | -33.52% |
Dec 30, 2022 | 502.99K | -60.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SS Innovations International | 1.83B |
Endo Inc. | 1.81B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 720.71M |
Elite Pharmaceuticals | 431.32M |
Glass House Brands | 378.35M |
Northwest Biotherapeutics | 290.30M |
CytoDyn | 287.97M |